Data by Company within Major Pharmaceutical Preparations Industry
|
|
Marketcap |
Revenues (TTM) |
Net Income (TTM) |
Employees |
Company |
(Millions) |
(Millions) |
(Millions) |
Number |
Eli Lilly And Company |
$ 474,035 |
$ 29,516 |
$ 6,498 |
35,000 |
Johnson and Johnson |
$ 413,539 |
$ 96,041 |
$ 19,157 |
141,700 |
Abbvie Inc |
$ 261,223 |
$ 56,023 |
$ 8,692 |
50,000 |
Merck and Co Inc |
$ 258,093 |
$ 52,525 |
$ 14,189 |
68,000 |
Beigene Ltd |
$ 242,800 |
$ 1,811 |
$ -1,728 |
4,344 |
Novartis Ag |
$ 223,083 |
$ 51,828 |
$ 6,955 |
110,000 |
Pfizer Inc |
$ 195,254 |
$ 92,367 |
$ 25,009 |
79,000 |
Glaxosmithkline Plc |
$ 182,742 |
$ 34,114 |
$ 5,096 |
99,437 |
Abbott Laboratories |
$ 167,726 |
$ 40,226 |
$ 5,161 |
113,000 |
Bristol myers Squibb Company |
$ 119,836 |
$ 45,187 |
$ 7,977 |
32,200 |
Astrazeneca Plc |
$ 104,099 |
$ 44,351 |
$ 3,293 |
76,100 |
Regeneron Pharmaceuticals Inc |
$ 93,174 |
$ 12,671 |
$ 4,299 |
10,368 |
Vertex Pharmaceuticals Inc |
$ 90,575 |
$ 9,505 |
$ 3,365 |
3,900 |
Gw Pharmaceuticals Plc |
$ 82,891 |
$ 343 |
$ -21 |
888 |
Zoetis Inc |
$ 79,957 |
$ 8,222 |
$ 2,209 |
12,100 |
Sanofi |
$ 67,345 |
$ 50,836 |
$ 9,502 |
100,000 |
Alexion Pharmaceuticals Inc |
$ 40,625 |
$ 6,262 |
$ 535 |
3,837 |
Theralink Technologies Inc |
$ 32,990 |
$ 1 |
$ -48 |
- |
Horizon Therapeutics Public Limited Company |
$ 27,120 |
$ 3,643 |
$ 438 |
1,450 |
Takeda Pharmaceutical Company Limited |
$ 23,987 |
$ 27,902 |
$ 2,196 |
- |
Zai Lab Limited |
$ 22,992 |
$ 252 |
$ -393 |
656 |
Akari Therapeutics Plc |
$ 22,553 |
- |
$ -18 |
15 |
Alnylam Pharmaceuticals Inc |
$ 22,309 |
$ 1,237 |
$ -1,064 |
1,450 |
Legend Biotech Corporation |
$ 18,296 |
$ 90 |
$ -386 |
345 |
Biomarin Pharmaceutical Inc |
$ 16,980 |
$ 2,235 |
$ 100 |
3,456 |
Royalty Pharma Plc |
$ 16,243 |
$ 2,361 |
$ 471 |
70 |
Hutchmed china Limited |
$ 14,164 |
$ 426 |
$ -360 |
406 |
Viatris Inc |
$ 12,060 |
$ 15,602 |
$ 1,854 |
37,000 |
Teva Pharmaceutical Industries Limited |
$ 11,211 |
$ 15,017 |
$ -2,331 |
40,000 |
Dr Reddy s Laboratories Limited |
$ 11,040 |
$ 2,992 |
$ 548 |
22,000 |
United Therapeutics Corporation |
$ 10,996 |
$ 2,111 |
$ 872 |
1,044 |
Sarepta Therapeutics Inc |
$ 10,524 |
$ 1,003 |
$ -908 |
1,400 |
Verona Pharma Plc |
$ 9,815 |
- |
$ -52 |
64 |
Prometheus Biosciences Inc |
$ 9,488 |
$ 4 |
$ -151 |
- |
Jazz Pharmaceuticals Plc |
$ 9,393 |
$ 4,039 |
$ -187 |
1,720 |
Pharming Group N v |
$ 8,323 |
$ 199 |
$ 16 |
180 |
Roivant Sciences Ltd |
$ 7,984 |
$ 79 |
$ -1,090 |
- |
Catalent Inc |
$ 7,774 |
$ 4,937 |
$ 378 |
19,000 |
Reata Pharmaceuticals Inc |
$ 7,154 |
$ 3 |
$ -88 |
339 |
Ionis Pharmaceuticals Inc |
$ 6,199 |
$ 585 |
$ -312 |
773 |
Arena Pharmaceuticals Inc |
$ 6,139 |
$ 3 |
$ -616 |
161 |
Karuna Therapeutics Inc |
$ 6,100 |
$ 11 |
$ -354 |
10 |
Puretech Health Plc |
$ 6,028 |
$ 16 |
$ -37 |
- |
Iveric Bio Inc |
$ 5,477 |
- |
$ -223 |
91 |
Elanco Animal Health Inc |
$ 5,399 |
$ 4,323 |
$ -98 |
6,550 |
Ascendis Pharma A |
$ 5,110 |
$ 57 |
$ -653 |
- |
Intra cellular Therapies Inc |
$ 5,036 |
$ 366 |
$ -184 |
200 |
Alkermes Plc |
$ 4,815 |
$ 1,462 |
$ 103 |
2,500 |
Global Blood Therapeutics Inc. |
$ 4,493 |
$ 235 |
$ -322 |
540 |
Apellis Pharmaceuticals Inc |
$ 4,444 |
$ 185 |
$ -657 |
- |
Perrigo Company Plc |
$ 4,202 |
$ 4,203 |
$ 149 |
- |
Organon and Co |
$ 4,169 |
$ 6,168 |
$ 754 |
9,300 |
Immunogen inc |
$ 4,155 |
$ 190 |
$ -182 |
200 |
Bridgebio Pharma Inc |
$ 4,079 |
$ 6 |
$ -584 |
- |
Structure Therapeutics Inc |
$ 4,056 |
- |
$ 0 |
- |
Turning Point Therapeutics Inc. |
$ 3,778 |
$ 1 |
$ -342 |
111 |
Chemocentryx Inc. |
$ 3,703 |
$ 75 |
$ -133 |
- |
Insmed Inc |
$ 3,490 |
$ 268 |
$ -696 |
400 |
Cerevel Therapeutics Holdings Inc |
$ 3,281 |
- |
$ -397 |
44 |
Amicus Therapeutics inc |
$ 3,230 |
$ 350 |
$ -185 |
1,246 |
Bausch Health Companies Inc |
$ 2,988 |
$ 8,350 |
$ -189 |
21,000 |
Dicerna Pharmaceuticals Inc |
$ 2,971 |
$ 193 |
$ -124 |
190 |
Blueprint Medicines Corporation |
$ 2,957 |
$ 202 |
$ -554 |
582 |
Axsome Therapeutics Inc |
$ 2,919 |
$ 182 |
$ -184 |
48 |
Chinook Therapeutics Inc |
$ 2,892 |
$ 6 |
$ -246 |
- |
Corcept Therapeutics Inc |
$ 2,881 |
$ 428 |
$ 94 |
289 |
Prestige Consumer Healthcare Inc |
$ 2,873 |
$ 1,129 |
$ -86 |
525 |
Arrowhead Pharmaceuticals Inc |
$ 2,809 |
$ 256 |
$ -184 |
211 |
Provention Bio Inc |
$ 2,683 |
$ 13 |
$ -114 |
- |
Cytokinetics Incorporated |
$ 2,676 |
$ 10 |
$ -540 |
202 |
Madrigal Pharmaceuticals Inc |
$ 2,625 |
- |
$ -330 |
36 |
Myovant Sciences Ltd |
$ 2,613 |
$ 379 |
$ -184 |
450 |
Nuvalent Inc |
$ 2,605 |
$ 4 |
$ -100 |
- |
Moonlake Immunotherapeutics |
$ 2,517 |
- |
$ -69 |
- |
Prothena Corporation Public Limited Company |
$ 2,474 |
$ 58 |
$ -141 |
- |
Ultragenyx Pharmaceutical Inc |
$ 2,467 |
$ 403 |
$ -721 |
1,000 |
Mirati Therapeutics Inc |
$ 2,445 |
$ 27 |
$ -738 |
- |
Amphastar Pharmaceuticals Inc |
$ 2,429 |
$ 541 |
$ 102 |
2,146 |
Acadia Pharmaceuticals Inc |
$ 2,392 |
$ 551 |
$ -111 |
780 |
Akero Therapeutics Inc |
$ 2,374 |
- |
$ -116 |
58 |
Dynavax Technologies Corporation |
$ 2,279 |
$ 459 |
$ 110 |
235 |
Galapagos Nv |
$ 2,259 |
$ 543 |
$ -116 |
1,429 |
Dice Therapeutics Inc |
$ 2,250 |
- |
$ -104 |
10 |
Xenon Pharmaceuticals Inc |
$ 2,177 |
$ 13 |
$ -164 |
- |
Schrodinger Inc |
$ 2,066 |
$ 194 |
$ 66 |
- |
Can fite Biopharma Ltd |
$ 2,031 |
$ 1 |
$ -10 |
- |
Harmony Biosciences Holdings inc |
$ 1,971 |
$ 499 |
$ 200 |
197 |
Trillium Therapeutics Inc |
$ 1,934 |
$ 0 |
$ 42 |
41 |
Ventyx Biosciences Inc |
$ 1,826 |
- |
$ -158 |
- |
Ironwood Pharmaceuticals inc |
$ 1,751 |
$ 394 |
$ 526 |
970 |
Evotec Se |
$ 1,670 |
$ 842 |
$ -197 |
3,072 |
Kadmon holdings inc |
$ 1,648 |
$ 16 |
$ -121 |
- |
Biohaven Ltd |
$ 1,643 |
$ 860 |
$ -731 |
274 |
Constellation Pharmaceuticals Inc |
$ 1,626 |
- |
$ -141 |
114 |
Ptc Therapeutics inc |
$ 1,566 |
$ 770 |
$ -571 |
700 |
Rocket Pharmaceuticals Inc |
$ 1,565 |
- |
$ -249 |
143 |
Pacira Biosciences inc |
$ 1,554 |
$ 669 |
$ -5 |
1,243 |
Cymabay Therapeutics Inc |
$ 1,500 |
- |
$ -81 |
27 |
Zogenix Inc |
$ 1,495 |
$ 82 |
$ -227 |
21,230 |
Supernus Pharmaceuticals inc |
$ 1,478 |
$ 634 |
$ 43 |
960 |
Crinetics Pharmaceuticals Inc |
$ 1,473 |
$ 5 |
$ -184 |
- |
Ideaya Biosciences Inc |
$ 1,453 |
$ 45 |
$ -74 |
- |
Taro Pharmaceutical Industries Ltd |
$ 1,403 |
$ 573 |
$ 25 |
5,860 |
Northwest Biotherapeutics inc |
$ 1,377 |
$ 2 |
$ -87 |
16 |
Biolinerx Ltd |
$ 1,362 |
- |
$ -27 |
53 |
Agios Pharmaceuticals Inc |
$ 1,347 |
$ 20 |
$ -210 |
- |
Catalyst Pharmaceuticals Inc |
$ 1,339 |
$ 303 |
$ 116 |
94 |
Radius Health inc. |
$ 1,326 |
$ 223 |
$ -69 |
250 |
Abcellera Biologics Inc |
$ 1,289 |
$ 145 |
$ -74 |
220 |
Maravai Lifesciences Holdings Inc |
$ 1,278 |
$ 544 |
$ 174 |
1,400 |
Amylyx Pharmaceuticals Inc |
$ 1,271 |
$ 192 |
$ -73 |
80 |
Arcus Biosciences Inc |
$ 1,266 |
$ 121 |
$ -287 |
21,164 |
Rhythm Pharmaceuticals inc |
$ 1,257 |
$ 51 |
$ -200 |
- |
Summit Therapeutics Inc |
$ 1,235 |
$ 2 |
$ -598 |
70 |
Imago Biosciences Inc |
$ 1,216 |
- |
$ -26 |
22 |
Kiniksa Pharmaceuticals Ltd |
$ 1,211 |
$ 281 |
$ 231 |
186 |
Zentalis Pharmaceuticals Inc |
$ 1,207 |
- |
$ -285 |
105 |
Cti Biopharma Corp |
$ 1,196 |
$ 76 |
$ -69 |
- |
Cincor Pharma Inc |
$ 1,186 |
- |
$ 0 |
- |
Sage Therapeutics Inc |
$ 1,181 |
$ 10 |
$ -592 |
- |
Xencor Inc |
$ 1,165 |
$ 113 |
$ -128 |
201 |
Innoviva Inc |
$ 1,165 |
$ 311 |
$ 217 |
540 |
Tg Therapeutics inc |
$ 1,155 |
$ 24 |
$ -176 |
132 |
Sierra Oncology Inc |
$ 1,153 |
- |
$ -103 |
- |
Opko Health Inc |
$ 1,150 |
$ 868 |
$ -209 |
4,500 |
Aeglea Biotherapeutics Inc |
$ 1,118 |
$ 1 |
$ -273 |
- |
Marizyme Inc |
$ 1,117 |
$ 0 |
$ -35 |
- |
Mirum Pharmaceuticals Inc |
$ 1,117 |
$ 116 |
$ -176 |
- |
Geron Corp |
$ 1,089 |
$ 0 |
$ -171 |
25 |
Merus N v |
$ 1,087 |
$ 41 |
$ -178 |
- |
Viking Therapeutics Inc |
$ 1,076 |
- |
$ -74 |
11 |
Deciphera Pharmaceuticals Inc |
$ 1,073 |
$ 144 |
$ -187 |
288 |
Mannkind Corporation |
$ 1,070 |
$ 158 |
$ -47 |
191 |
89bio Inc |
$ 1,069 |
- |
$ -119 |
20 |
Eqrx Inc |
$ 1,065 |
- |
$ -262 |
- |
Aurinia Pharmaceuticals Inc |
$ 1,062 |
$ 160 |
$ -73 |
71 |
Ligand Pharmaceuticals Incorporated |
$ 1,049 |
$ 163 |
$ 27 |
149 |
Ani Pharmaceuticals Inc |
$ 1,015 |
$ 401 |
$ -5 |
685 |
Arvinas Inc |
$ 1,006 |
$ 163 |
$ -423 |
133 |
Tango Therapeutics Inc |
$ 994 |
$ 34 |
$ -107 |
- |
Disc Medicine Inc |
$ 981 |
- |
$ -63 |
- |
Collegium Pharmaceutical inc |
$ 975 |
$ 494 |
$ -11 |
253 |
Pliant Therapeutics Inc |
$ 950 |
$ 5 |
$ -144 |
- |
Syndax Pharmaceuticals Inc |
$ 940 |
$ 140 |
$ -160 |
38 |
Revance Therapeutics Inc |
$ 937 |
$ 186 |
$ -2 |
348 |
Mei Pharma Inc |
$ 930 |
$ 49 |
$ -32 |
- |
Protagonist Therapeutics inc |
$ 928 |
$ 45 |
$ -138 |
- |
Keros Therapeutics Inc |
$ 912 |
- |
$ -127 |
60 |
Calliditas Therapeutics Ab |
$ 904 |
$ 86 |
$ -44 |
60 |
Day One Biopharmaceuticals Inc |
$ 900 |
- |
$ -28 |
- |
Morphic Holding inc |
$ 890 |
$ 69 |
$ -130 |
- |
Gracell Biotechnologies Inc |
$ 876 |
- |
$ -88 |
365 |
Albireo Pharma inc |
$ 868 |
$ 57 |
$ -131 |
- |
Ardelyx inc |
$ 841 |
$ 63 |
$ -66 |
- |
Intercept Pharmaceuticals inc |
$ 776 |
$ 277 |
$ 209 |
452 |
Avadel Pharmaceuticals Plc |
$ 767 |
$ 44 |
$ -143 |
- |
Zealand Pharma A |
$ 754 |
$ 293 |
$ -1,018 |
390 |
Sinovac Biotech Ltd |
$ 739 |
$ 1,493 |
$ 88 |
1,000 |
Verve Therapeutics Inc |
$ 730 |
$ 5 |
$ -192 |
- |
Cogent Biosciences Inc |
$ 714 |
$ 8 |
$ -157 |
- |
Point Biopharma Global Inc |
$ 707 |
- |
$ 97 |
50 |
Cassava Sciences Inc |
$ 702 |
- |
$ -90 |
- |
Mereo Biopharma Group Plc |
$ 695 |
$ 36 |
$ 13 |
46 |
Arcturus Therapeutics Holdings Inc |
$ 681 |
$ 264 |
$ 80 |
122 |
Amneal Pharmaceuticals Inc |
$ 646 |
$ 2,094 |
$ -273 |
6,500 |
Cryoport inc |
$ 640 |
$ 241 |
$ -47 |
31 |
Travere Therapeutics Inc |
$ 640 |
$ 226 |
$ -307 |
500 |
Wave Life Sciences Ltd |
$ 635 |
$ 37 |
$ -131 |
- |
Pharvaris N v |
$ 622 |
- |
$ -48 |
- |
Genelux Corporation |
$ 620 |
- |
$ 0 |
- |
Aslan Pharmaceuticals Limited |
$ 613 |
$ 3 |
$ -32 |
- |
Rapt Therapeutics Inc |
$ 613 |
$ 3 |
$ -99 |
41 |
Bicycle Therapeutics Plc |
$ 602 |
$ 23 |
$ -140 |
- |
Kura Oncology Inc |
$ 600 |
- |
$ -140 |
66 |
Xtl Biopharmaceuticals Ltd |
$ 585 |
- |
$ -1 |
- |
Avid Bioservices Inc |
$ 577 |
$ 150 |
$ -3 |
326 |
Biodelivery Sciences International Inc |
$ 575 |
$ 167 |
$ 85 |
120 |
Vera Therapeutics Inc |
$ 573 |
- |
$ -107 |
- |
Enliven Therapeutics Inc |
$ 560 |
- |
$ -4 |
- |
Tyra Biosciences Inc |
$ 557 |
- |
$ -51 |
- |
Thorne Healthtech Inc |
$ 549 |
$ 256 |
$ 20 |
- |
Alpine Immune Sciences Inc |
$ 546 |
$ 29 |
$ -59 |
36 |
Savara Inc |
$ 544 |
- |
$ -43 |
- |
Centessa Pharmaceuticals Plc |
$ 535 |
- |
$ -173 |
350 |
Aveo Pharmaceuticals Inc |
$ 519 |
$ 95 |
$ -29 |
- |
Phibro Animal Health Corporation |
$ 513 |
$ 977 |
$ 33 |
1,400 |
Repare Therapeutics Inc |
$ 496 |
$ 167 |
$ -3 |
124 |
Evolus Inc |
$ 493 |
$ 169 |
$ -66 |
130 |
Entrada Therapeutics Inc |
$ 492 |
- |
$ -67 |
89 |
Phathom Pharmaceuticals Inc |
$ 492 |
- |
$ -185 |
55 |
Theravance Biopharma inc |
$ 492 |
$ 51 |
$ 869 |
- |
Akouos inc |
$ 490 |
- |
$ -93 |
148 |
Dyne Therapeutics Inc |
$ 477 |
$ 3,055 |
$ -189 |
- |
Olema Pharmaceuticals inc |
$ 475 |
- |
$ -97 |
30 |
Anaptysbio inc |
$ 469 |
$ 13 |
$ -144 |
- |
Flexion Therapeutics Inc |
$ 458 |
$ 100 |
$ -101 |
215 |
Aclaris Therapeutics Inc |
$ 458 |
$ 31 |
$ -105 |
- |
Gh Research Plc |
$ 450 |
- |
$ -9 |
- |
Biomea Fusion Inc |
$ 449 |
- |
$ -102 |
33 |
23andme Holding Co |
$ 441 |
$ 296 |
$ -327 |
700 |
Avidity Biosciences Inc |
$ 424 |
$ 10 |
$ -193 |
- |
Harrow Health Inc |
$ 423 |
$ 103 |
$ -16 |
257 |
Kindred Biosciences Inc |
$ 419 |
$ 8 |
$ -42 |
- |
Zymeworks Inc |
$ 416 |
$ 448 |
$ 186 |
600 |
Concert Pharmaceuticals Inc |
$ 416 |
$ 33 |
$ -186 |
107 |
Liquidia Corporation |
$ 404 |
$ 18 |
$ -51 |
- |
Janux Therapeutics Inc |
$ 397 |
$ 8 |
$ -68 |
- |
Marinus Pharmaceuticals Inc |
$ 396 |
$ 26 |
$ -28 |
- |
Organogenesis Holdings Inc |
$ 395 |
$ 456 |
$ 9 |
896 |
Nurix Therapeutics Inc |
$ 392 |
$ 61 |
$ -157 |
100 |
Adamas Pharmaceuticals Inc |
$ 375 |
$ 88 |
$ -63 |
120 |
Siga Technologies Inc |
$ 371 |
$ 98 |
$ 28 |
60 |
Edgewise Therapeutics inc |
$ 366 |
- |
$ -10 |
14 |
Ars Pharmaceuticals Inc |
$ 364 |
- |
$ -23 |
- |
Procaps Group S a |
$ 364 |
$ 410 |
$ 43 |
- |
Lyell Immunopharma Inc |
$ 358 |
$ 48 |
$ -210 |
- |
Aldeyra Therapeutics Inc |
$ 356 |
- |
$ -52 |
152 |
Terns Pharmaceuticals Inc |
$ 350 |
- |
$ -72 |
51 |
Molecular Templates inc |
$ 350 |
$ 20 |
$ 93 |
45 |
Amarin Corp Plcuk |
$ 345 |
$ 277 |
$ -38 |
1,040 |
Nature s Sunshine Products inc |
$ 334 |
$ 432 |
$ 6 |
2,100 |
Aerovate Therapeutics inc |
$ 329 |
- |
$ -65 |
10 |
Igm Biosciences Inc |
$ 326 |
- |
$ -234 |
170 |
Urogen Pharma Ltd |
$ 321 |
$ 72 |
$ -109 |
- |
Precigen Inc |
$ 320 |
- |
$ 22 |
- |
Nanobiotix S a |
$ 320 |
$ 5 |
$ -64 |
- |
Arbutus Biopharma Corp |
$ 319 |
$ 24 |
$ -8 |
93 |
Compass Pathways Plc |
$ 313 |
- |
$ -102 |
76 |
Kalvista Pharmaceuticals Inc |
$ 309 |
$ 13 |
$ -95 |
- |
An2 Therapeutics Inc |
$ 302 |
$ 1 |
$ -54 |
- |
Uniqure N v |
$ 294 |
$ 112 |
$ -187 |
- |
Arcutis Biotherapeutics Inc |
$ 290 |
$ 12 |
$ -331 |
68 |
Erasca Inc |
$ 290 |
- |
$ -226 |
100 |
Nuvation Bio Inc |
$ 289 |
- |
$ -90 |
- |
Tonix Pharmaceuticals Holding Corp |
$ 279 |
- |
$ -98 |
- |
Seres Therapeutics Inc |
$ 279 |
$ 130 |
$ -153 |
- |
Macrogenics Inc |
$ 279 |
$ 152 |
$ 7 |
423 |
Pmv Pharmaceuticals Inc |
$ 272 |
- |
$ -74 |
- |
Redhill Biopharma Ltd |
$ 269 |
$ 62 |
$ 72 |
158 |
Oric Pharmaceuticals Inc |
$ 269 |
- |
$ -93 |
51 |
Innovation Pharmaceuticals Inc |
$ 266 |
- |
$ -3 |
- |
Liminal Biosciences Inc |
$ 256 |
$ 0 |
$ 9 |
790 |
Fulcrum Therapeutics Inc |
$ 256 |
$ 3 |
$ -98 |
- |
Scpharmaceuticals Inc |
$ 254 |
- |
$ -45 |
2,191 |
Ovid Therapeutics Inc |
$ 251 |
$ 0 |
$ -49 |
51 |
Atea Pharmaceuticals Inc |
$ 250 |
$ 351 |
$ -106 |
12 |
I mab |
$ 247 |
- |
$ -364 |
- |
Epizyme Inc. |
$ 245 |
$ 53 |
$ -208 |
- |
Kamada Ltd |
$ 240 |
$ 104 |
$ -2 |
495 |
Xeris Biopharma Holdings Inc |
$ 240 |
$ 121 |
$ -33 |
100 |
Vanda Pharmaceuticals Inc |
$ 240 |
$ 238 |
$ 15 |
500 |
Chiasma Inc |
$ 236 |
- |
$ -90 |
87 |
Y mabs Therapeutics inc |
$ 234 |
$ 40 |
$ -117 |
- |
Ocular Therapeutix Inc |
$ 230 |
$ 55 |
$ -91 |
- |
Mineralys Therapeutics Inc |
$ 226 |
- |
$ 0 |
- |
Neoleukin Therapeutics Inc |
$ 222 |
- |
$ -61 |
- |
Enanta Pharmaceuticals Inc |
$ 221 |
$ 81 |
$ -132 |
112 |
Morphosys Ag |
$ 214 |
$ 201 |
$ -576 |
434 |
Ac Immune Sa |
$ 213 |
- |
$ -73 |
109 |
Reneo Pharmaceuticals Inc |
$ 212 |
- |
$ -61 |
- |
Generation Bio Co |
$ 211 |
- |
$ -127 |
174 |
Lexicon Pharmaceuticals Inc |
$ 209 |
$ 0 |
$ -131 |
219 |
Akebia Therapeutics Inc |
$ 208 |
$ 292 |
$ -94 |
384 |
Spectrum Pharmaceuticals Inc |
$ 208 |
$ 109 |
$ -65 |
1 |
Immuneering Corporation |
$ 203 |
$ 0 |
$ -52 |
11 |
2seventy Bio Inc |
$ 202 |
$ 147 |
$ -180 |
- |
Regulus Therapeutics Inc |
$ 201 |
$ 0 |
$ -27 |
50 |
Trevi Therapeutics Inc |
$ 200 |
- |
$ -27 |
30 |
Acelyrin Inc |
$ 200 |
- |
$ 0 |
- |
Synlogic Inc |
$ 200 |
$ 1 |
$ -65 |
- |
Eagle Pharmaceuticals inc |
$ 200 |
$ 258 |
$ 12 |
261 |
Applied Therapeutics Inc |
$ 199 |
- |
$ -73 |
- |
Astria Therapeutics inc |
$ 198 |
- |
$ -49 |
10 |
Acrivon Therapeutics Inc |
$ 198 |
- |
$ -27 |
- |
Chemomab Therapeutics Ltd |
$ 197 |
- |
$ 31 |
9 |
Alx Oncology Holdings Inc |
$ 197 |
- |
$ -130 |
17 |
Atai Life Sciences N v |
$ 193 |
$ 0 |
$ -150 |
- |
Allakos Inc |
$ 191 |
- |
$ -151 |
149 |
Rockwell Medical inc |
$ 190 |
$ 62 |
$ -33 |
- |
Foghorn Therapeutics Inc |
$ 186 |
$ 22 |
$ -115 |
- |
Verrica Pharmaceuticals Inc |
$ 184 |
$ 9 |
$ -23 |
- |
Rigel Pharmaceuticals Inc |
$ 179 |
$ 127 |
$ -38 |
135 |
Pasithea Therapeutics Corp |
$ 179 |
$ 0 |
$ -17 |
- |
China Health Industries Holdings Inc |
$ 177 |
$ 0 |
$ 0 |
- |
Inozyme Pharma Inc |
$ 176 |
- |
$ -68 |
56 |
Merrimack Pharmaceuticals Inc |
$ 175 |
- |
$ -3 |
117 |
Omeros Corporation |
$ 174 |
- |
$ 40 |
450 |
Nuvectis Pharma inc |
$ 173 |
- |
$ 0 |
- |
Carisma Therapeutics Inc |
$ 172 |
- |
$ -23 |
- |
Assertio Holdings inc |
$ 172 |
$ 168 |
$ 98 |
300 |
Inventiva S a |
$ 167 |
- |
$ -56 |
- |
Larimar Therapeutics Inc |
$ 166 |
- |
$ -33 |
110 |
Stoke Therapeutics Inc |
$ 163 |
$ 9 |
$ -105 |
- |
Annexon Inc |
$ 162 |
- |
$ -143 |
52 |
Zomedica Corp |
$ 162 |
$ 21 |
$ -19 |
- |
Xoma Corporation |
$ 161 |
$ 4 |
$ -31 |
- |
Vaxxinity Inc |
$ 161 |
- |
$ -72 |
- |
Cormedix Inc |
$ 161 |
$ 0 |
$ -37 |
17 |
Emergent Biosolutions Inc |
$ 160 |
$ 1,074 |
$ -608 |
2,100 |
Zevra Therapeutics Inc |
$ 160 |
$ 17 |
$ -32 |
- |
Selecta Biosciences Inc |
$ 160 |
$ 49 |
$ -35 |
60 |
Lianbio |
$ 156 |
- |
$ 0 |
600 |
F star Therapeutics Inc |
$ 156 |
- |
$ -44 |
56 |
Cytodyn Inc |
$ 148 |
- |
$ -80 |
25 |
Actinium Pharmaceuticals Inc |
$ 147 |
$ 1 |
$ -46 |
23 |
Mersana Therapeutics inc |
$ 146 |
$ 39 |
$ -215 |
- |
Cyclerion Therapeutics Inc |
$ 146 |
$ 2 |
$ -38 |
- |
Pds Biotechnology Corp |
$ 145 |
- |
$ -48 |
20 |
Clever Leaves Holdings Inc |
$ 140 |
$ 17 |
$ -57 |
- |
Karyopharm Therapeutics Inc |
$ 139 |
$ 146 |
$ -142 |
315 |
Verastem Inc |
$ 139 |
$ 4 |
$ -75 |
73 |
Strongbridge Biopharma plc |
$ 136 |
$ 35 |
$ -40 |
156 |
Ys Biopharma Co Ltd |
$ 135 |
$ 100 |
$ -21 |
- |
Optinose Inc |
$ 133 |
$ 72 |
$ -46 |
- |
Prelude Therapeutics Inc |
$ 131 |
- |
$ 27 |
11 |
Pardes Biosciences Inc |
$ 130 |
- |
$ -76 |
- |
Essa Pharma inc |
$ 130 |
$ 1 |
$ -27 |
18 |
Milestone Pharmaceuticals Inc |
$ 129 |
- |
$ -59 |
47 |
Altimmune inc |
$ 129 |
- |
$ -81 |
50 |
Design Therapeutics Inc |
$ 128 |
- |
$ -74 |
- |
Rallybio Corporation |
$ 127 |
- |
$ -71 |
- |
Paratek Pharmaceuticals Inc |
$ 127 |
$ 167 |
$ -66 |
200 |
Vaccitech Plc |
$ 123 |
$ 13 |
$ -55 |
- |
Decibel Therapeutics Inc |
$ 123 |
- |
$ -63 |
- |
Biophytis Sa |
$ 122 |
- |
$ -35 |
- |
Oncolytics Biotech Inc |
$ 121 |
- |
$ -19 |
- |
Puma Biotechnology Inc |
$ 121 |
$ 230 |
$ -2 |
460 |
Heron Therapeutics Inc |
$ 118 |
$ 118 |
$ -137 |
336 |
Xbiotech Inc |
$ 117 |
$ 8 |
$ -28 |
- |
Praxis Precision Medicines Inc |
$ 116 |
- |
$ -157 |
- |
Inflarx N v |
$ 116 |
- |
$ -33 |
100 |
Aadi Bioscience Inc |
$ 116 |
$ 22 |
$ -62 |
- |
Greenwich Lifesciences Inc |
$ 115 |
- |
$ -7 |
- |
Galectin Therapeutics Inc |
$ 114 |
- |
$ -40 |
11 |
Longboard Pharmaceuticals Inc |
$ 113 |
- |
$ -49 |
- |
Theseus Pharmaceuticals Inc |
$ 112 |
- |
$ -58 |
- |
Pepgen Inc |
$ 110 |
- |
$ -69 |
- |
Scynexis Inc |
$ 109 |
$ 136 |
$ 44 |
100 |
Nektar Therapeutics |
$ 108 |
$ 88 |
$ -307 |
725 |
Reviva Pharmaceuticals Holdings Inc |
$ 106 |
- |
$ -31 |
12 |
Opiant Pharmaceuticals Inc |
$ 106 |
$ 22 |
$ -33 |
- |
Esperion Therapeutics Inc |
$ 106 |
$ 88 |
$ -222 |
- |
Entasis Therapeutics Holdings Inc |
$ 105 |
- |
$ -52 |
25 |
Eton Pharmaceuticals Inc |
$ 103 |
$ 29 |
$ 0 |
- |
Oramed Pharmaceuticals Inc |
$ 103 |
$ 3 |
$ 23 |
21 |
Citius Pharmaceuticals Inc |
$ 103 |
- |
$ -31 |
1 |
Cyteir Therapeutics Inc |
$ 102 |
$ 1,545 |
$ -41 |
46 |
Viveon Health Acquisition Corp |
$ 101 |
- |
$ 0 |
- |
Immunome Inc |
$ 100 |
- |
$ -39 |
- |
Medicinova Inc |
$ 100 |
- |
$ -12 |
8 |
Ngm Biopharmaceuticals Inc |
$ 96 |
$ 30 |
$ -170 |
- |
Elite Pharmaceuticals Inc |
$ 95 |
$ 33 |
$ 3 |
67 |
Anixa Biosciences Inc |
$ 95 |
- |
$ -11 |
15 |
Cue Biopharma Inc |
$ 94 |
$ 2 |
$ -52 |
50 |
Biovie Inc |
$ 93 |
- |
$ 44 |
6 |
Briacell Therapeutics Corp |
$ 92 |
- |
$ 0 |
- |
Relmada Therapeutics Inc |
$ 92 |
- |
$ -129 |
11 |
Atossa Therapeutics Inc |
$ 90 |
- |
$ -32 |
9 |
Syros Pharmaceuticals Inc |
$ 90 |
$ 9 |
$ -95 |
- |
Cara Therapeutics inc |
$ 89 |
$ 27 |
$ -112 |
- |
Spruce Biosciences Inc |
$ 88 |
- |
$ -48 |
- |
Ocean Biomedical Inc |
$ 87 |
- |
$ -69 |
- |
Chimerix inc |
$ 86 |
$ 34 |
$ 180 |
181 |
Lifevantage Corp |
$ 85 |
$ 213 |
$ 3 |
247 |
Flora Growth Corp |
$ 84 |
- |
$ 0 |
- |
Benitec Biopharma Inc |
$ 84 |
$ 0 |
$ -20 |
- |
Sonnet Biotherapeutics Holdings Inc |
$ 84 |
$ 0 |
$ -30 |
- |
Kezar Life Sciences Inc |
$ 83 |
- |
$ -83 |
- |
Cytomx Therapeutics Inc |
$ 83 |
$ 66 |
$ -56 |
138 |
G1 Therapeutics Inc |
$ 83 |
$ 89 |
$ -78 |
- |
Annovis Bio inc |
$ 81 |
- |
$ -30 |
812 |
Anebulo Pharmaceuticals Inc |
$ 80 |
- |
$ -12 |
- |
Aquestive Therapeutics Inc |
$ 80 |
$ 47 |
$ -23 |
- |
Fibrogen Inc |
$ 79 |
$ 131 |
$ -322 |
832 |
Pyxis Oncology Inc |
$ 79 |
- |
$ -99 |
11 |
Ocuphire Pharma Inc |
$ 76 |
- |
$ 19 |
- |
Prophase Labs Inc |
$ 75 |
$ 78 |
$ -4 |
24 |
Capricor Therapeutics inc |
$ 75 |
$ 9 |
$ -29 |
11 |
Aptorum Group Limited |
$ 75 |
- |
$ -27 |
31 |
Glycomimetics Inc |
$ 74 |
$ 1 |
$ -50 |
- |
Aditxt Inc |
$ 74 |
$ 1 |
$ -27 |
- |
Gossamer Bio Inc |
$ 73 |
- |
$ -207 |
62 |
Werewolf Therapeutics Inc |
$ 73 |
$ 25 |
$ -41 |
- |
Kronos Bio Inc |
$ 72 |
- |
$ -120 |
57 |
Bioxcel Therapeutics Inc |
$ 71 |
$ 1 |
$ -203 |
51 |
Affimed N v |
$ 70 |
$ 45 |
$ -64 |
- |
Eliem Therapeutics Inc |
$ 70 |
- |
$ -45 |
- |
Intercure Ltd |
$ 70 |
$ 389 |
$ 44 |
11 |
Diamedica Therapeutics Inc |
$ 68 |
- |
$ -17 |
- |
Tiziana Life Sciences Ltd |
$ 68 |
- |
$ -15 |
- |
Corvus Pharmaceuticals Inc |
$ 67 |
- |
$ -39 |
- |
Hcw Biologics Inc |
$ 66 |
$ 4 |
$ -19 |
- |
Homology Medicines Inc |
$ 66 |
$ 3 |
$ -132 |
- |
Kinnate Biopharma Inc |
$ 66 |
- |
$ -127 |
- |
Veru Inc |
$ 64 |
$ 15 |
$ -110 |
1,300 |
Nkarta Inc |
$ 64 |
- |
$ -125 |
- |
Shattuck Labs Inc |
$ 64 |
$ 1 |
$ -92 |
- |
Zynerba Pharmaceuticals Inc |
$ 64 |
- |
$ -38 |
- |
Rezolute Inc |
$ 64 |
- |
$ -52 |
- |
Immunic Inc |
$ 63 |
- |
$ -127 |
- |
Proqr Therapeutics N v |
$ 63 |
- |
$ 0 |
100 |
Spero Therapeutics Inc |
$ 63 |
$ 54 |
$ -10 |
- |
Vaccinex Inc |
$ 62 |
$ 1 |
$ 0 |
- |
Durect Corp |
$ 62 |
$ 19 |
$ -36 |
- |
Immix Biopharma Inc |
$ 60 |
- |
$ -8 |
- |
Eyenovia inc |
$ 59 |
- |
$ -25 |
7 |
Xilio Therapeutics inc |
$ 58 |
- |
$ -84 |
51 |
Adicet Bio Inc |
$ 56 |
$ 39 |
$ -115 |
50 |
Sigilon Therapeutics Inc |
$ 56 |
$ 18 |
$ -30 |
- |
Ampio Pharmaceuticals inc |
$ 55 |
$ 0 |
$ -14 |
- |
Connect Biopharma Holdings Limited |
$ 54 |
- |
$ -114 |
- |
Clearside Biomedical Inc |
$ 54 |
$ 2 |
$ -36 |
- |
Tyme Technologies Inc. |
$ 54 |
- |
$ -24 |
- |
Rani Therapeutics Holdings Inc |
$ 52 |
- |
$ -69 |
100 |
Journey Medical Corporation |
$ 50 |
$ 61 |
$ -39 |
- |
Hookipa Pharma inc |
$ 49 |
$ 16 |
$ -68 |
- |
Murphy Canyon Acquisition Corp |
$ 48 |
- |
$ 1 |
- |
Longeveron Inc |
$ 48 |
$ 0 |
$ -4 |
- |
Kyto Technology And Life Science Inc |
$ 46 |
$ 0 |
$ 1 |
- |
Kineta Inc |
$ 45 |
$ 9 |
$ -73 |
- |
Sellas Life Sciences Group Inc |
$ 45 |
- |
$ -36 |
- |
Assembly Biosciences Inc |
$ 44 |
$ 79 |
$ -81 |
- |
Immunoprecise Antibodies Ltd |
$ 44 |
$ 16 |
$ -20 |
- |
Intec Pharma Ltd |
$ 43 |
- |
$ -14 |
- |
Odonate Therapeutics Inc |
$ 42 |
- |
$ -102 |
10 |
Magenta Therapeutics Inc |
$ 42 |
- |
$ -69 |
- |
Clene Inc |
$ 42 |
$ 1 |
$ -49 |
- |
Rapid Therapeutic Science Laboratories Inc |
$ 42 |
- |
$ 0 |
- |
Dar Bioscience Inc |
$ 41 |
- |
$ -40 |
10 |
Gain Therapeutics inc |
$ 41 |
$ 0 |
$ -22 |
- |
Vtv Therapeutics Inc |
$ 40 |
$ 5 |
$ -25 |
- |
Bolt Biotherapeutics Inc |
$ 40 |
$ 7 |
$ -77 |
- |
Societal Cdmo Inc |
$ 40 |
$ 89 |
$ -20 |
- |
Viracta Therapeutics Inc |
$ 40 |
- |
$ -74 |
- |
Celularity Inc |
$ 40 |
$ 15 |
$ -83 |
201 |
Io Biotech Inc |
$ 39 |
- |
$ -74 |
- |
Marker Therapeutics inc |
$ 39 |
$ 13 |
$ -13 |
- |
Coya Therapeutics Inc |
$ 39 |
- |
$ 0 |
- |
Mainz Biomed N v |
$ 39 |
$ 1 |
$ -26 |
- |
Eledon Pharmaceuticals Inc |
$ 37 |
- |
$ -89 |
- |
Minerva Neurosciences Inc |
$ 37 |
- |
$ -27 |
- |
Sol gel Technologies Ltd |
$ 37 |
$ 31 |
$ 3 |
- |
Satsuma Pharmaceuticals Inc |
$ 36 |
- |
$ -65 |
- |
Nextcure Inc |
$ 36 |
- |
$ -70 |
- |
Lantern Pharma Inc |
$ 36 |
- |
$ -14 |
- |
Oculis Holding Ag |
$ 35 |
- |
$ 0 |
- |
Casi Pharmaceuticals inc |
$ 35 |
$ 43 |
$ -40 |
- |
Betterlife Pharma Inc. |
$ 35 |
$ 339 |
$ -9 |
45 |
Fortress Biotech Inc |
$ 35 |
$ 63 |
$ -225 |
- |
Provectus Biopharmaceuticals Inc |
$ 34 |
$ 1 |
$ -3 |
- |
Maia Biotechnology Inc |
$ 33 |
- |
$ -5 |
- |
Cellectar Biosciences Inc |
$ 32 |
- |
$ -37 |
- |
Adc Therapeutics Sa |
$ 32 |
$ 34 |
$ -230 |
- |
Beyondspring Inc |
$ 31 |
$ 1 |
$ -36 |
- |
Rain Oncology Inc |
$ 31 |
- |
$ -83 |
- |
Vistagen Therapeutics Inc |
$ 31 |
$ 1 |
$ -46 |
- |
Alaunos Therapeutics Inc |
$ 31 |
- |
$ -37 |
- |
Protagenic Therapeutics Inc new |
$ 31 |
- |
$ -4 |
- |
Therapeuticsmd Inc |
$ 31 |
$ 23 |
$ 43 |
325 |
Orphazyme A |
$ 30 |
$ 36 |
$ -627 |
- |
Unity Biotechnology Inc |
$ 30 |
- |
$ -48 |
- |
Nucana Plc |
$ 30 |
- |
$ -41 |
- |
Sio Gene Therapies Inc |
$ 29 |
- |
$ -29 |
- |
Mallinckrodt Plc |
$ 29 |
$ 2,142 |
$ -847 |
3,600 |
Enlivex Therapeutics Ltd |
$ 28 |
- |
$ -31 |
- |
Lumos Pharma Inc |
$ 28 |
$ 2 |
$ -32 |
- |
Qilian International Holding Group Limited |
$ 28 |
$ 65 |
$ 1 |
- |
Universe Pharmaceuticals Inc |
$ 28 |
$ 40 |
$ -9 |
- |
Corbus Pharmaceuticals Holdings Inc |
$ 28 |
$ 2 |
$ -46 |
57 |
Matinas Biopharma Holdings Inc |
$ 27 |
$ 4 |
$ -20 |
230 |
Neubase Therapeutics inc |
$ 27 |
- |
$ -28 |
- |
Effector Therapeutics Inc |
$ 27 |
- |
$ -37 |
- |
Biora Therapeutics Inc |
$ 27 |
$ 0 |
$ -54 |
- |
Agex Therapeutics Inc |
$ 27 |
- |
$ -5 |
- |
Innovation1 Biotech Inc |
$ 26 |
$ 0 |
$ -46 |
- |
Cumberland Pharmaceuticals Inc |
$ 26 |
$ 41 |
$ -2 |
96 |
Seelos Therapeutics inc |
$ 26 |
$ 1 |
$ -81 |
- |
Checkpoint Therapeutics inc |
$ 25 |
$ 0 |
$ -59 |
19 |
Pieris Pharmaceuticals Inc |
$ 25 |
$ 33 |
$ -27 |
- |
Equillium Inc |
$ 25 |
- |
$ -18 |
- |
Metacrine Inc |
$ 25 |
- |
$ -38 |
- |
Alimera Sciences Inc |
$ 24 |
$ 58 |
$ -24 |
- |
Landos Biopharma Inc |
$ 24 |
- |
$ 2 |
- |
Indaptus Therapeutics Inc |
$ 23 |
- |
$ -15 |
- |
Cell Source Inc |
$ 23 |
- |
$ -6 |
- |
Athenex Inc |
$ 23 |
$ 103 |
$ -104 |
1,115 |
Intelgenx Technologies Corp |
$ 23 |
$ 1 |
$ -11 |
- |
Sensei Biotherapeutics Inc |
$ 23 |
- |
$ -45 |
- |
Novabay Pharmaceuticals Inc |
$ 23 |
$ 9 |
$ -4 |
- |
Context Therapeutics Inc |
$ 23 |
- |
$ -19 |
- |
Vincerx Pharma Inc |
$ 22 |
- |
$ -56 |
- |
Lftd Partners Inc |
$ 22 |
$ 48 |
$ 3 |
- |
Priveterra Acquisition Corp |
$ 22 |
- |
$ -3 |
- |
Kala Bio inc |
$ 21 |
$ 6 |
$ -9 |
- |
Alzamend Neuro Inc |
$ 21 |
- |
$ -15 |
- |
Nrx Pharmaceuticals Inc |
$ 21 |
- |
$ -39 |
- |
Acasti Pharma Inc |
$ 21 |
- |
$ -42 |
- |
Evelo Biosciences Inc |
$ 21 |
- |
$ -101 |
- |
Bioxytran Inc |
$ 21 |
- |
$ -3 |
- |
Bullfrog Ai Holdings Inc |
$ 20 |
- |
$ 0 |
- |
Neptune Wellness Solutions Inc |
$ 20 |
$ 47 |
$ -89 |
208 |
Rasna Therapeutics Inc |
$ 20 |
$ 0 |
$ -4 |
- |
Genprex Inc |
$ 19 |
- |
$ -30 |
- |
Vascular Biogenics Ltd |
$ 19 |
$ 1 |
$ 66 |
- |
Leap Therapeutics inc |
$ 19 |
$ 2 |
$ -82 |
- |
Igc Pharma Inc |
$ 19 |
$ 1 |
$ -11 |
- |
Cocrystal Pharma Inc |
$ 19 |
$ 2 |
$ -20 |
11 |
Acer Therapeutics Inc |
$ 19 |
- |
$ -39 |
- |
Neurobo Pharmaceuticals Inc |
$ 19 |
- |
$ -11 |
- |
Bright Minds Biosciences Inc |
$ 19 |
- |
$ -11 |
- |
Palatin Technologies Inc |
$ 19 |
$ 5 |
$ -28 |
- |
Catalyst Biosciences Inc |
$ 19 |
$ 7 |
$ 26 |
- |
Oncternal Therapeutics Inc |
$ 18 |
$ 1 |
$ -43 |
- |
Galecto Inc |
$ 18 |
- |
$ -52 |
- |
Hepion Pharmaceuticals inc |
$ 18 |
- |
$ -43 |
- |
Orgenesis Inc |
$ 18 |
$ 36 |
$ 11 |
111 |
Acurx Pharmaceuticals inc |
$ 17 |
- |
$ -13 |
- |
Scisparc Ltd |
$ 17 |
$ 1 |
$ 3 |
- |
Virios Therapeutics inc |
$ 16 |
- |
$ -4 |
- |
Promis Neurosciences inc |
$ 16 |
- |
$ -5 |
- |
Addex Therapeutics Ltd |
$ 16 |
$ 3 |
$ -15 |
- |
Teligent Inc |
$ 16 |
$ 46 |
$ -92 |
- |
Mustang Bio inc |
$ 16 |
- |
$ -75 |
330 |
Integrated Biopharma Inc |
$ 16 |
$ 50 |
$ 0 |
- |
Nanoviricides inc |
$ 16 |
- |
$ -7 |
- |
Onconova Therapeutics inc |
$ 15 |
$ 0 |
$ -19 |
10 |
Medicenna Therapeutics Corp. |
$ 15 |
- |
$ -17 |
- |
Nls Pharmaceutics Ltd |
$ 15 |
- |
$ -16 |
- |
Skye Bioscience Inc |
$ 15 |
- |
$ -21 |
- |
Geovax Labs Inc |
$ 15 |
$ 0 |
$ -19 |
- |
Aprea Therapeutics Inc |
$ 15 |
- |
$ -14 |
- |
Inhibitor Therapeutics Inc |
$ 15 |
- |
$ 11 |
- |
Lipocine Inc |
$ 15 |
$ 1 |
$ -12 |
- |
Chembio Diagnostics Inc |
$ 15 |
$ 50 |
$ -23 |
- |
Calcimedica Inc |
$ 14 |
- |
$ -43 |
- |
Unicycive Therapeutics Inc |
$ 14 |
- |
$ -29 |
- |
Frequency Therapeutics Inc |
$ 14 |
$ 35 |
$ -67 |
51 |
Ainos Inc |
$ 13 |
$ 3 |
$ -15 |
- |
Edesa Biotech Inc |
$ 13 |
- |
$ -9 |
- |
Nighthawk Biosciences inc |
$ 13 |
$ 8 |
$ -52 |
- |
Aravive Inc |
$ 13 |
$ 9 |
$ -77 |
- |
Nascent Biotech Inc |
$ 13 |
$ 0 |
$ -2 |
- |
Forte Biosciences Inc |
$ 13 |
- |
$ -24 |
- |
Moleculin Biotech Inc |
$ 13 |
- |
$ -29 |
- |
Rvl Pharmaceuticals Plc |
$ 13 |
$ 36 |
$ -68 |
- |
Vyne Therapeutics Inc |
$ 13 |
$ 0 |
$ -35 |
- |
Immune Therapeutics Inc |
$ 12 |
- |
$ -4 |
- |
Tff Pharmaceuticals Inc |
$ 12 |
$ 1 |
$ -27 |
- |
Aeterna Zentaris Inc |
$ 12 |
$ 5 |
$ -8 |
- |
Biofrontera Inc |
$ 12 |
$ 70 |
$ -23 |
- |
Eterna Therapeutics Inc |
$ 12 |
- |
$ -22 |
50 |
Renovorx Inc |
$ 12 |
- |
$ -10 |
- |
Gelesis Holdings Inc |
$ 12 |
$ 12 |
$ -53 |
- |
Clovis Oncology inc |
$ 12 |
$ 133 |
$ -252 |
461 |
Oncotelic Therapeutics Inc |
$ 11 |
- |
$ -17 |
- |
Dominari Holdings Inc |
$ 11 |
- |
$ -26 |
- |
Immutep Ltd |
$ 11 |
$ 4 |
$ -30 |
- |
Aytu Biopharma inc |
$ 11 |
$ 104 |
$ -32 |
20 |
Celyad Oncology Sa |
$ 11 |
$ 0 |
$ -30 |
- |
Atreca inc |
$ 10 |
- |
$ -85 |
- |
Gt Biopharma Inc |
$ 10 |
- |
$ -15 |
- |
Bellicum Pharmaceuticals Inc |
$ 10 |
$ 1 |
$ -4 |
- |
Iterum Therapeutics Plc |
$ 10 |
- |
$ -56 |
- |
Apexigen Inc |
$ 10 |
- |
$ -40 |
- |
Guardion Health Sciences Inc |
$ 10 |
$ 11 |
$ -11 |
- |
Virpax Pharmaceuticals Inc |
$ 10 |
- |
$ -15 |
- |
Imunon Inc |
$ 10 |
$ 1 |
$ -31 |
- |
Inmed Pharmaceuticals Inc |
$ 9 |
$ 5 |
$ -13 |
- |
Impel Pharmaceuticals Inc |
$ 9 |
$ 7 |
$ -92 |
- |
Accustem Sciences Inc |
$ 9 |
- |
$ -3 |
- |
Lipella Pharmaceuticals Inc |
$ 9 |
- |
$ 0 |
- |
Diffusion Pharmaceuticals Inc |
$ 9 |
- |
$ -13 |
- |
Timber Pharmaceuticals Inc |
$ 9 |
$ 1 |
$ -15 |
- |
Athersys Inc |
$ 9 |
$ 5 |
$ -93 |
- |
Cohbar Inc |
$ 9 |
- |
$ -13 |
- |
Blue Water Biotech Inc |
$ 8 |
- |
$ -14 |
- |
Cadrenal Therapeutics Inc |
$ 8 |
- |
$ 0 |
- |
Shuttle Pharmaceuticals Holdings Inc |
$ 8 |
- |
$ -6 |
- |
Cingulate Inc |
$ 8 |
- |
$ -19 |
- |
Monopar Therapeutics Inc |
$ 8 |
- |
$ -10 |
- |
Theriva Biologics inc |
$ 8 |
- |
$ -19 |
- |
Obseva Sa |
$ 8 |
- |
$ 0 |
- |
Lucy Scientific Discovery Inc |
$ 8 |
- |
$ 0 |
- |
Obseva Sa |
$ 8 |
$ 20 |
$ -58 |
- |
Galera Therapeutics Inc |
$ 7 |
- |
$ -71 |
- |
Trevena inc |
$ 7 |
$ 0 |
$ -38 |
- |
Applied Molecular Transport Inc |
$ 7 |
- |
$ -93 |
- |
Jaguar Health inc |
$ 7 |
$ 11 |
$ -46 |
- |
Pulmatrix Inc |
$ 7 |
$ 6 |
$ -19 |
- |
Cv Sciences Inc |
$ 7 |
$ 15 |
$ 1 |
- |
Processa Pharmaceuticals Inc |
$ 7 |
- |
$ -26 |
- |
Aileron Therapeutics Inc |
$ 7 |
- |
$ -17 |
62 |
Tenax Therapeutics Inc |
$ 7 |
- |
$ 8 |
- |
Kintara Therapeutics Inc |
$ 6 |
- |
$ -15 |
- |
One World Products Inc |
$ 6 |
$ 0 |
$ -1 |
- |
Tricida Inc |
$ 6 |
- |
$ -61 |
- |
Exicure Inc |
$ 6 |
$ 29 |
$ 3 |
- |
Lexaria Bioscience Corp |
$ 6 |
$ 0 |
$ -11 |
- |
Oragenics Inc |
$ 6 |
$ 0 |
$ -12 |
14 |
Regen Biopharma Inc |
$ 6 |
$ 0 |
$ 7 |
3 |
Acelrx Pharmaceuticals Inc |
$ 6 |
$ 2 |
$ -32 |
- |
Comera Life Sciences Holdings Inc |
$ 6 |
$ 1 |
$ -13 |
- |
Xortx Therapeutics Inc |
$ 6 |
$ 0 |
$ -1 |
- |
Vbi Vaccines Inc |
$ 6 |
$ 2 |
$ -119 |
- |
Neximmune Inc |
$ 5 |
- |
$ -49 |
- |
Avenue Therapeutics Inc |
$ 5 |
- |
$ -12 |
- |
Qualigen Therapeutics Inc |
$ 5 |
$ 6 |
$ -20 |
- |
Hoth Therapeutics Inc |
$ 5 |
- |
$ -10 |
- |
Axim Biotechnologies Inc |
$ 5 |
$ 0 |
$ -9 |
- |
Bellerophon Therapeutics inc |
$ 5 |
- |
$ -12 |
- |
Enveric Biosciences Inc |
$ 5 |
- |
$ -22 |
- |
Ayala Pharmaceuticals Inc |
$ 5 |
$ 4 |
$ -28 |
- |
Evoke Pharma Inc |
$ 5 |
$ 4 |
$ -8 |
- |
First Wave Biopharma Inc |
$ 5 |
- |
$ -64 |
- |
Agile Therapeutics Inc |
$ 5 |
$ 16 |
$ -11 |
28 |
Aptinyx Inc |
$ 5 |
$ 2 |
$ -66 |
- |
Nabriva Therapeutics Plc |
$ 5 |
$ 37 |
$ -54 |
123 |
Cyclacel Pharmaceuticals Inc |
$ 4 |
- |
$ -24 |
- |
Cns Pharmaceuticals Inc |
$ 4 |
- |
$ -18 |
- |
Peak Pharmaceuticals Inc |
$ 4 |
- |
$ 0 |
- |
Tempest Therapeutics Inc |
$ 4 |
- |
$ -33 |
- |
Paxmedica Inc |
$ 4 |
- |
$ -7 |
- |
Immuron Limited |
$ 4 |
$ 1 |
$ -4 |
- |
Soligenix inc |
$ 4 |
- |
$ -18 |
- |
Artelo Biosciences Inc |
$ 4 |
- |
$ -9 |
- |
Revelation Biosciences Inc |
$ 4 |
- |
$ 2 |
- |
Lixte Biotechnology Holdings Inc |
$ 4 |
- |
$ -6 |
- |
Petros Pharmaceuticals inc |
$ 4 |
- |
$ 0 |
- |
Gri Bio Inc |
$ 4 |
- |
$ -12 |
- |
Phasebio Pharmaceuticals Inc. |
$ 3 |
$ 1 |
$ -103 |
- |
Azitra Inc |
$ 3 |
- |
$ 0 |
- |
Abvc Biopharma Inc |
$ 3 |
$ 1 |
$ -12 |
- |
180 Life Sciences Corp |
$ 3 |
- |
$ -52 |
- |
Ensysce Biosciences Inc |
$ 3 |
$ 3 |
$ -20 |
- |
Ibio inc |
$ 3 |
$ 2 |
$ -65 |
- |
Bio path Holdings Inc |
$ 3 |
- |
$ -17 |
- |
Adial Pharmaceuticals Inc |
$ 3 |
- |
$ -8 |
- |
Emmaus Life Sciences Inc |
$ 3 |
$ 28 |
$ -5 |
- |
Synaptogenix Inc |
$ 3 |
- |
$ 12 |
- |
Aridis Pharmaceuticals Inc |
$ 3 |
$ 3 |
$ -29 |
- |
Hst Global Inc |
$ 3 |
- |
$ 0 |
- |
Dermata Therapeutics Inc |
$ 3 |
- |
$ -8 |
- |
Plx Pharma Inc |
$ 2 |
$ 5 |
$ -25 |
- |
Novan Inc |
$ 2 |
$ 25 |
$ -32 |
- |
Zyversa Therapeutics Inc |
$ 2 |
- |
$ 0 |
- |
Zosano Pharma Corporation |
$ 2 |
$ 1 |
$ -55 |
- |
Aptevo Therapeutics Inc |
$ 2 |
$ 13 |
$ -17 |
- |
Histogen Inc |
$ 2 |
$ 0 |
$ -12 |
- |
Contrafect Corporation |
$ 2 |
- |
$ -36 |
27 |
Regenerx Biopharmaceuticals inc |
$ 2 |
$ 0 |
$ -2 |
- |
Adamis Pharmaceuticals Corporation |
$ 2 |
$ 5 |
$ -25 |
- |
Adhera Therapeutics Inc |
$ 2 |
$ 2,732 |
$ -3 |
11 |
Kiora Pharmaceuticals Inc |
$ 2 |
- |
$ -12 |
- |
Endo International Plc |
$ 2 |
$ 2,160 |
$ -946 |
4,050 |
Salarius Pharmaceuticals inc |
$ 2 |
$ 5 |
$ -30 |
- |
Globestar Therapeutics Corporation |
$ 2 |
- |
$ -2 |
- |
60 Degrees Pharmaceuticals Inc |
$ 2 |
- |
$ 0 |
- |
Procyon Corporation |
$ 2 |
$ 5 |
$ 0 |
- |
Avalo Therapeutics Inc |
$ 2 |
$ 17 |
$ 17 |
- |
Humanigen Inc |
$ 2 |
$ 2 |
$ -54 |
- |
Scopus Biopharma Inc |
$ 2 |
- |
$ -9 |
- |
Novaccess Global Inc |
$ 2 |
- |
$ -3 |
- |
Nexien Biopharma Inc |
$ 2 |
- |
$ 0 |
- |
Sagimet Biosciences inc |
$ 1 |
- |
$ 0 |
- |
China Pharma Holdings Inc |
$ 1 |
$ 8 |
$ -3 |
- |
Bespoke Extracts Inc |
$ 1 |
$ 0 |
$ -3 |
- |
Kazia Therapeutics Limited |
$ 1 |
$ 15 |
$ -8 |
- |
Bioadaptives Inc |
$ 1 |
$ 0 |
$ -1 |
- |
9 Meters Biopharma Inc |
$ 1 |
- |
$ -46 |
27 |
International Stem Cell Corporation |
$ 1 |
$ 8 |
$ 0 |
- |
Panbela Therapeutics Inc |
$ 1 |
- |
$ -20 |
- |
Sangui Biotech International Inc |
$ 1 |
$ 0 |
$ 0 |
- |
Nanomix Corp |
$ 1 |
- |
$ -12 |
- |
Infinity Pharmaceuticals Inc |
$ 1 |
$ 3 |
$ -41 |
23 |
Oncosec Medical Incorporated |
$ 1 |
- |
$ -29 |
- |
Oncorus Inc |
$ 1 |
- |
$ -91 |
- |
Transcode Therapeutics Inc |
$ 1 |
- |
$ -19 |
- |
Otonomy Inc |
$ 1 |
$ 0 |
$ -52 |
- |
The Greater Cannabis Company Inc |
$ 1 |
- |
$ 0 |
- |
Rebus Holdings Inc |
$ 0 |
- |
$ 1 |
- |
Wellness Center Usa Inc |
$ 0 |
$ 0 |
$ -2 |
- |
Skinvisible Inc |
$ 0 |
$ 0 |
$ -2 |
- |
Lannett Company Inc |
$ 0 |
$ 289 |
$ -274 |
- |
Calithera Biosciences Inc |
$ 0 |
$ 27 |
$ -21 |
- |
Allarity Therapeutics Inc |
$ 0 |
$ 24 |
$ -20 |
- |
Evofem Biosciences Inc |
$ 0 |
$ 15 |
$ 67 |
- |
Third Harmonic Bio Inc |
$ 0 |
- |
$ 17 |
- |
American Bio Medica Corporation |
$ 0 |
$ 1 |
$ 1 |
- |
Clearmind Medicine Inc |
$ 0 |
- |
$ -7 |
1 |
Musclepharm Corporation |
$ 0 |
$ 50 |
$ -19 |
248 |
Altamira Therapeutics Ltd |
$ 0 |
$ 0 |
$ -27 |
- |
Respirerx Pharmaceuticals Inc |
$ 0 |
- |
$ -3 |
- |
Generex Biotechnology Corp |
$ 0 |
$ 4 |
$ -37 |
- |
Sunwin Stevia International Inc. |
$ 0 |
$ 37 |
$ -4 |
421 |
Abeona Therapeutics Inc |
$ 0 |
$ 5 |
$ -36 |
- |
Q Biomed inc |
$ 0 |
$ 0 |
$ -1 |
8 |
Fsd Pharma Inc |
$ 0 |
- |
$ -24 |
- |
Acura Pharmaceuticals inc |
$ 0 |
$ 2 |
$ -1 |
- |
Statera Biopharma Inc fka Cytocom Inc |
$ 0 |
$ 4 |
$ -103 |
- |
Khosla Ventures Acquisition Co |
$ 0 |
- |
$ 6 |
- |
Hillstream Biopharma Inc |
$ 0 |
- |
$ -9 |
- |
Cardax Inc |
$ 0 |
$ 1 |
$ -5 |
- |
Kaya Holdings Inc |
- |
$ 0 |
$ -6 |
17 |
Cen Biotech Inc |
- |
- |
$ 2 |
- |
Cnbx Pharmaceuticals Inc |
- |
$ 0 |
$ -4 |
- |
Cannapharmarx Inc |
- |
- |
$ -8 |
- |
Earth Science Tech Inc |
- |
$ 0 |
$ 0 |
- |
Galmed Pharmaceuticals Ltd |
- |
$ 2 |
$ 18 |
- |
Angion Biomedica Corp |
- |
$ 30 |
$ -24 |
- |
4d Pharma Plc |
- |
$ 1 |
$ -32 |
- |
Protokinetix Incorporated |
- |
- |
$ -2 |
- |
Propanc Biopharma Inc |
- |
- |
$ -3 |
- |
Sunshine Biopharma Inc |
- |
$ 15 |
$ -25 |
- |
Alterity Therapeutics Limited |
- |
- |
$ 0 |
- |
Xenetic Biosciences Inc |
- |
$ 2 |
$ -4 |
- |
Neuropathix Inc. |
- |
$ 0 |
$ -4 |
- |
Avricore Health Inc |
- |
$ 1 |
$ -1 |
- |
Medicure Inc |
- |
$ 18 |
$ 1 |
- |
Phio Pharmaceuticals Corp |
- |
- |
$ -12 |
- |
Grifols Sa |
- |
- |
$ 304 |
- |
Stealth Biotherapeutics Corp |
- |
- |
$ -53 |
- |
Intellipharmaceutics International Inc |
- |
$ 0 |
$ -3 |
- |
Renovaro Biosciences Inc |
- |
- |
$ -40 |
- |
Sonoma Pharmaceuticals Inc |
- |
$ 13 |
$ -6 |
- |
Purple Biotech Ltd |
- |
- |
$ 22 |
- |
Painreform Ltd |
- |
- |
$ -7 |
- |
Silence Therapeutics Plc |
- |
$ 12 |
$ -39 |
- |
Amryt Pharma Plc |
- |
$ 223 |
$ 0 |
1 |
Biodexa Pharmaceuticals Plc |
- |
$ 1 |
$ -8 |
- |
Avenir Wellness Solutions Inc |
- |
$ 5 |
$ -26 |
- |
Landec Corporation |
- |
$ 451 |
$ -64 |
- |
Major Pharmaceutical Preparations Industry |
$ 3,745,831 |
$ 789,161 |
$ 75,263 |
1,237,282 |
Recent News from Major Pharmaceutical Preparations Industry |
Renovaro Biosciences Inc
Renovaro Biosciences Inc, a major pharmaceutical preparations company, has released its financial report for the fiscal period ending June 30, 2023. During this period, the company experienced zero gain per share, an improvement compared to the same period a year ago when it reported a gain of $0.33 per share. It also represents an increase from the preceding financial reporting period when the company reported a loss of $0.08 per share. In terms of revenue, Renovaro Biosciences Inc did not experience any change compared to the corresponding financial reporting period a year ago. The revenue remained at $0.00 million, and there was no sequential change either. This stability in revenue could be an area of concern for the company, as it suggests a lack of growth or expansion in its operations.
|
|
Immuron Limited
In the financial fourth quarter of 2023, Immuron Limited, a major pharmaceutical preparations company, reported its financial results, which revealed a decrease in revenue and widened net loss. These figures mark a notable change compared to the corresponding financial reporting period from the previous year. This article aims to examine the context behind Immuron Limited's financial results, including its stock performance and implications for investors. Financial Results: Immuron Limited disclosed a revenue of $1.480365 million in the financial fourth quarter of 2023 after experiencing a net loss of $-3.787 million. These figures signify a departure from balanced books in the corresponding period a year earlier. Additionally, in the financial year 2023, the company announced a loss of $-3.79 million alongside a revenue of $1.48 million. In comparison to the prior financial year, the net loss per share has widened from $-1.25 to $-1.66, indicating a financial decline. However, it is important to note that the net loss remained unchanged from $0.00 million a year earlier.
|
|
Procyon Corporation
Procyon Corporation recently released their financial results for the fourth quarter of the 2023 earnings season. While the company reported unaltered earnings per share (EPS), a decline in revenue and other key indicators raises concerns about the company's future performance. This article aims to interpret the financial results and discuss their potential impact on Procyon Corporation going forward. 1. Earnings per Share (EPS) and Revenue Performance: Procyon Corporation maintained an EPS of $0.00 in the fourth quarter, suggesting stability in their profitability. However, the company experienced a modest revenue decline of -0.589% year-on-year, amounting to $1.20 million. This decline sets Procyon apart from the rest of the Major Pharmaceutical Preparations industry, which recorded a revenue improvement during the same period.
|
|
Innovation Pharmaceuticals Inc
Innovation Pharmaceuticals Inc, a pharmaceutical company, recently announced its financial results for the fiscal year ending June 30, 2023. During this period, the company achieved a break-even point of $0.00 per share, which was the same as the previous year and the previous quarter. However, the company did not generate any revenue during this quarter, remaining at $0.00 million, the same as the previous year and quarter. This indicates that there was no growth in the company's revenue during this period. Additionally, Innovation Pharmaceuticals Inc reported a net shortfall of $-0.681 million for the fiscal year ending June 30, 2023. This is a significant improvement compared to the deficit of $-1.626 million reported in the same quarter a year ago. Although still in a shortfall, the company has managed to reduce its losses, which may indicate positive efforts in managing their expenses.
|
|
Palatin Technologies Inc
Financial News Report: Palatin Technologies Inc Reports Strong Revenue Growth in Q4 2023, Despite Stock Deficit Palatin Technologies Inc (PTN) has announced a substantial revenue advancement of 109.038% year on year to $1.76 million in the fourth quarter of 2023. However, the company posted a deficit per stock at $-0.98. Despite the stock deficit, PTN's revenue experienced significant growth compared to its peers in the Major Pharmaceutical Preparations industry. Most corporations in this industry saw an average revenue advance of 3.04% during the same period. In comparison to the preceding reporting period, PTN's revenue surged by 47.359% from $1.20 million and the deficit improved from $0.00 per share. This strong revenue growth indicates a positive trend for Palatin Technologies Inc.
|
|
Ibio Inc
In the aftermath of Ibio Inc's recently released fourth-quarter earnings report, the company appears to be grappling with mounting losses and a steep decline in its share value. The financial results for the quarter ended in 2023 revealed a concerning trend of escalating losses for the biotechnology firm. Earnings Overview: During the fourth quarter of the 2023 earnings season, Ibio Inc reported a significant increase in its loss per share compared to the same period in the prior year. The loss per share surged from $-0.10 a year ago to $-0.97, representing a substantial deterioration. Additionally, the company witnessed a sequential increase in losses, reaching $-0.55 per share from the previous financial reporting period.
|
|
Mei Pharma Inc
Date: November 15, 2023 Mei Pharma Inc, a leading pharmaceutical company, has experienced a significant turnaround in their financial performance during the financial fourth quarter of 2023, with a reduction in losses per share and improved earnings per share. However, the company witnessed a sharp decline in revenue compared to the previous year, mainly attributed to slowing demand and other market factors. During the financial fourth quarter of 2023, Mei Pharma Inc reduced their loss per share from $-0.13 a year ago to $-0.08 per share, indicating a 38.46% improvement. Furthermore, earnings per share showed a significant improvement from $-2.32 per share in the preceding quarter to the current figure. These positive numbers highlight the company's ability to manage their expenses effectively and generate better returns for their shareholders.
|
|
Dividend
XOMA Corporation, a biotechnology company based in Emeryville, California, announced today that their Board of Directors has approved cash dividends for holders of XOMA's Series A and Series B Cumulative Preferred Stock. This news comes amidst a troubled period for XOMA's stock performance, with a decline of -3.75% over the past week and a YTD performance of -16.08%. However, there is a ray of hope as the stock is currently trading 14.5% above its 52-week low. The declaration of quarterly preferred stock dividends by XOMA is a positive move for the company and its shareholders. Dividends are a way for companies to distribute profits to their stockholders, creating an additional incentive for investors to hold onto their shares. By authorizing these cash dividends, XOMA is demonstrating its commitment to rewarding its investors and maintaining a strong relationship with them.
|
|
Cannapharmarx Inc
The first quarter of 2023 has shown significant promise for Cannapharmarx Inc, a major player in the pharmaceutical preparations industry. While the company has not revealed any top-line figures yet, industry observers are examining the operating shortfall of $-0.720277 million, shedding light on the positive performance of the firm during this period. By comparing it to previous quarters and assessing other growth indicators, we can anticipate a bullish outlook for Cannapharmarx Inc in the near future. Reduced Losses and Growing Revenue: In the first quarter of 2022, Cannapharmarx Inc experienced an operating shortfall of $-0.715558 million. However, with effective cost-cutting measures and revenue growth strategies, the company has managed to improve its financial performance in Q1 2023. The company's losses of $-2.072 million in the first quarter of 2022 have been reduced to $-1.413 million, showcasing a significant improvement in their bottom line. This reduction of losses is indicative of a more efficient and profitable operation.
|
|
Benitec Biopharma Inc
Financial News Report: Benitec Biopharma Inc Reports Loss in Fiscal Year 2023 Benitec Biopharma Inc, a major pharmaceutical preparations company, recently released its financial results for the fiscal interval ending June 30, 2023. The company reported a net loss of $-4.661 million, compared to a deficit of $-5.067 million in the corresponding reporting season a year ago. In terms of earnings per share (EPS), Benitec Biopharma Inc experienced a decline from $-0.16 per share in the previous reporting season to $-0.17 per share in the current period. However, this is an improvement compared to the earnings of $-0.62 per share a year before the reporting season.
|
|
|
|
|
|